Michele Oneil/Legacy Builders
What you need to know about this purported money-making opportunity.
Fust et al. v. Gilead Sciences, Inc.
23-at-1244, E.D. Cal.
(Sept. 2023)
Remdesivir
Falsely marketing Remdesivir as safe and effective against COVID-19 without disclosing its limitations and adverse events, including fatalities
Pending
What you need to know about this purported money-making opportunity.
How a donation made on this fundraising platform can turn into a costly transaction.
Lawsuits accuse tax prep companies of violating the Military Lending Act.
Katie Mather, HuffPost
TINA.org digs into company’s subscription terms.